MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Stock Holdings in Stryker Co. (NYSE:SYK)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Stryker Co. (NYSE:SYK - Free Report) by 1.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 60,503 shares of the medical technology company's stock after buying an additional 754 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Stryker were worth $21,784,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Kohmann Bosshard Financial Services LLC purchased a new stake in Stryker during the 4th quarter valued at approximately $25,000. Rakuten Securities Inc. boosted its position in shares of Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after acquiring an additional 68 shares during the last quarter. Centricity Wealth Management LLC purchased a new position in Stryker during the fourth quarter valued at $30,000. BankPlus Trust Department bought a new stake in Stryker in the 4th quarter valued at $33,000. Finally, VSM Wealth Advisory LLC purchased a new stake in Stryker in the 4th quarter worth $36,000. 77.09% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on SYK shares. Canaccord Genuity Group lifted their target price on Stryker from $420.00 to $435.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. Stifel Nicolaus lifted their price objective on Stryker from $400.00 to $440.00 and gave the stock a "buy" rating in a research note on Wednesday, January 29th. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Citigroup reissued a "buy" rating and issued a $450.00 target price on shares of Stryker in a report on Wednesday, February 26th. Finally, Sanford C. Bernstein set a $450.00 price target on shares of Stryker in a research note on Monday, May 5th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $427.05.

Insider Buying and Selling at Stryker

In related news, Director Allan C. Golston sold 2,458 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the sale, the director now owns 14,895 shares in the company, valued at $5,705,827.65. This represents a 14.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director now directly owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This represents a 5.53% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by company insiders.

Stryker Stock Up 0.5%

Shares of NYSE SYK traded up $2.04 during mid-day trading on Friday, reaching $394.24. 1,113,972 shares of the company were exchanged, compared to its average volume of 1,348,571. Stryker Co. has a 1 year low of $314.93 and a 1 year high of $406.19. The firm has a 50-day moving average of $366.62 and a 200 day moving average of $375.47. The stock has a market cap of $150.48 billion, a price-to-earnings ratio of 50.80, a P/E/G ratio of 2.93 and a beta of 0.93. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, topping the consensus estimate of $2.73 by $0.11. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The firm had revenue of $5.87 billion during the quarter, compared to analyst estimates of $5.68 billion. During the same quarter in the previous year, the business posted $2.50 EPS. Stryker's revenue was up 11.9% on a year-over-year basis. On average, research analysts expect that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 0.85%. The ex-dividend date of this dividend is Monday, June 30th. Stryker's dividend payout ratio is presently 45.41%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.